Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al. · Journal of Chronic Diseases · 1987 · 49.9K citations

Public Health, Biostatistics, Clinical Classification Systems +15

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study

Ethan Basch, Alexia Iasonos, Tiffani L. McDonough et al. · The Lancet Oncology · 2006 · 657 citations

Nursing, Oncology, Health Assessment +14

How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30

Erik K. Fromme, Kristine M. Eilers, Motomi Mori et al. · Journal of Clinical Oncology · 2004 · 565 citations

Medicine, Oncology, Pharmacotherapy +16

Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer

Stephen E. Jones, John K. Erban, Beth Overmoyer et al. · Journal of Clinical Oncology · 2005 · 547 citations · Full text

Medicine, Oncology, Pharmacology +14

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies

Vinay Chaudhry, Eric K. Rowinsky, S E Sartorius et al. · Annals of Neurology · 1994 · 369 citations

Medicine, Oncology, Pharmacology +15